ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy
Investigational New Drugs
◽
10.1007/s10637-014-0179-1
◽
2014
◽
Vol 33
(1)
◽
pp. 201-214
◽
Cited By ~ 209
Author(s):
Suzanne Leijen
◽
Sjaak A. Burgers
◽
Paul Baas
◽
Dick Pluim
◽
Matthijs Tibben
◽
...
Keyword(s):
Lung Cancer
◽
Phase I
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
Small Cell Lung
◽
First Line
◽
First Line Therapy
◽
Line Therapy
◽
Ruthenium Compound
Download Full-text
Related Documents
Cited By
References
Phase I/II Trial of Docetaxel and Carboplatin as a First-Line Therapy in Patients with Stage IV Non-Small-Cell Lung Cancer
Lung
◽
10.1007/s00408-005-2572-1
◽
2006
◽
Vol 184
(3)
◽
pp. 133-139
◽
Cited By ~ 3
Author(s):
Kensuke Kataoka
◽
Ryujiro Suzuki
◽
Hiroyuki Taniguchi
◽
Yasunobu Noda
◽
Joe Shindoh
◽
...
Keyword(s):
Lung Cancer
◽
Phase I
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Stage Iv
◽
Small Cell
◽
Small Cell Lung
◽
First Line
◽
First Line Therapy
◽
Line Therapy
Download Full-text
Abstract 1803: Phase I/II study of bortezomib in combination with carboplatin and bevacizumab as first line therapy in patients with advanced non-small cell lung cancer (NSCLC)
10.1158/1538-7445.am10-1803
◽
2010
◽
Author(s):
Bilal Piperdi
◽
Kendra J. Bradley
◽
Venu Bathini
◽
Colleens M. Zekos
◽
Meredith Hanrahan-Boshes
◽
...
Keyword(s):
Lung Cancer
◽
Phase I
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
Small Cell Lung
◽
First Line
◽
First Line Therapy
◽
Line Therapy
Download Full-text
A phase I/II study using oral topotecan (OT) with intravenous paclitaxel (P) as first-line therapy for patients (pts) with advanced non-small cell lung cancer (NSCLC)
Lung Cancer
◽
10.1016/s0169-5002(00)80017-3
◽
2000
◽
Vol 29
(1)
◽
pp. 7
Author(s):
J.R Eckardt
◽
M.P Fanucchi
◽
D.J Stewart
◽
R.A Beckman
◽
T.W Dobbs
◽
...
Keyword(s):
Lung Cancer
◽
Phase I
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
Small Cell Lung
◽
First Line
◽
First Line Therapy
◽
Line Therapy
◽
Oral Topotecan
Download Full-text
A phase I/II study using oral topotecan (OT) with intravenous paclitaxel (P) as first-line therapy for patients (pts) with advanced non-small cell lung cancer (NSCLC)
Lung Cancer
◽
10.1016/s0169-5002(00)80013-6
◽
2000
◽
Vol 29
(1)
◽
pp. 6
Author(s):
J.R Eckardt
◽
M.P Fanucchi
◽
D.J Stewart
◽
R.A Beckman
◽
T.W Dobbs
◽
...
Keyword(s):
Lung Cancer
◽
Phase I
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
Small Cell Lung
◽
First Line
◽
First Line Therapy
◽
Line Therapy
◽
Oral Topotecan
Download Full-text
A phase I study of nintedanib combined with cisplatin/gemcitabine as first-line therapy for advanced squamous non-small cell lung cancer (LUME-Lung 3)
Lung Cancer
◽
10.1016/j.lungcan.2018.03.007
◽
2018
◽
Vol 120
◽
pp. 27-33
◽
Cited By ~ 6
Author(s):
Martin Forster
◽
Allan Hackshaw
◽
Tommaso De Pas
◽
Manuel Cobo
◽
Pilar Garrido
◽
...
Keyword(s):
Lung Cancer
◽
Phase I
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Phase I Study
◽
Small Cell
◽
Small Cell Lung
◽
First Line
◽
First Line Therapy
◽
Line Therapy
Download Full-text
Phase-I/II Study of Bortezomib in Combination with Carboplatin and Bevacizumab as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer
Journal of Thoracic Oncology
◽
10.1097/jto.0b013e31824de2fa
◽
2012
◽
Vol 7
(6)
◽
pp. 1032-1040
◽
Cited By ~ 21
Author(s):
Bilal Piperdi
◽
William V. Walsh
◽
Kendra Bradley
◽
Zheng Zhou
◽
Venu Bathini
◽
...
Keyword(s):
Lung Cancer
◽
Phase I
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
Small Cell Lung
◽
First Line
◽
First Line Therapy
◽
Line Therapy
Download Full-text
Faculty Opinions recommendation of Safety and efficacy of weekly nab®-paclitaxel in combination with carboplatin as first-line therapy in elderly patients with advanced non-small-cell lung cancer.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.717964584.793468557
◽
2013
◽
Author(s):
Bruno Andreoni
◽
Gianmarco Contino
Keyword(s):
Lung Cancer
◽
Elderly Patients
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
Small Cell Lung
◽
First Line
◽
Safety And Efficacy
◽
First Line Therapy
◽
Line Therapy
Download Full-text
Cytotoxic Chemotherapy as First-Line Therapy for Advanced Non-Small-Cell Lung Cancer in Taiwan: Daily Practice
Journal of Cancer
◽
10.7150/jca.15180
◽
2016
◽
Vol 7
(11)
◽
pp. 1515-1523
◽
Cited By ~ 3
Author(s):
Yi-Hsin Liang
◽
Yu-Yun Shao
◽
Bin-Chi Liao
◽
Ho-Sheng Lee
◽
James Chih-Hsin Yang
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Daily Practice
◽
Cytotoxic Chemotherapy
◽
Small Cell
◽
Small Cell Lung
◽
First Line
◽
First Line Therapy
◽
Line Therapy
Download Full-text
Pembrolizumab and platinum-based chemotherapy as first-line therapy for advanced non–small-cell lung cancer: Phase 1 cohorts from the KEYNOTE-021 study
Lung Cancer
◽
10.1016/j.lungcan.2018.08.019
◽
2018
◽
Vol 125
◽
pp. 273-281
◽
Cited By ~ 26
Author(s):
Shirish M. Gadgeel
◽
James P. Stevenson
◽
Corey J. Langer
◽
Leena Gandhi
◽
Hossein Borghaei
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Phase 1
◽
Small Cell
◽
Small Cell Lung
◽
First Line
◽
First Line Therapy
◽
Line Therapy
◽
Platinum Based Chemotherapy
Download Full-text
Nab-Paclitaxel in combination with Cisplatin Versus Docetaxel Plus Cisplatin as First-Line Therapy in Non-small Cell Lung Cancer
Scientific Reports
◽
10.1038/s41598-017-11404-9
◽
2017
◽
Vol 7
(1)
◽
Cited By ~ 9
Author(s):
Yi Chen
◽
Jinyu Li
◽
Shixue Chen
◽
Yibao Zhang
◽
Yi Hu
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
Small Cell Lung
◽
First Line
◽
First Line Therapy
◽
Line Therapy
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close